<DOC>
	<DOC>NCT00087516</DOC>
	<brief_summary>The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.</brief_summary>
	<brief_title>Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients with type 2 diabetes mellitus Patient is not pregnant or breastfeeding Male or female patient unlikely to conceive Patient not on an antihyperglycemic drug Patient has history of type 1 diabetes mellitus Patient has history of ketoacidosis Patient requires insulin within 8 weeks prior to start of study Patient on weight loss program and is not in maintenance phase Patient taking weight loss medication within 8 weeks prior to start of study Patient on or likely to require = 14 days or repeated courses of corticosteroids Patient taking immunosuppressive/immunomodulating medication Patient taking digoxin or other cardiac medication Patient has undergone surgical general anesthesia within 30 days prior to start of study Patient taking investigational drug within 8 weeks prior to start of study Patient is diagnosed with liver disease Patient has chronic myopathy, progressive neurological/neuromuscular disorder Patient has with severe cardiac conditions within the last 6 months Patient is Human immunodeficiency virus (HIV) positive Patient has hematological disorder Patient has history of malignancy Patient has history of alcohol or drug abuse within the past 3 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>